[Protein drugs can be designed now. Targeting and cancer destroying drugs soon available].
Josephson
S
S
Sektionen för klinisk immunologi och transfusionsmedicin, Uppsala universitet, samt Akademiska sjukhuset.
Lind
P
P
Tötterman
T
T
D000970:Antineoplastic Agents / Q000737:chemistry*; D001709:Biotechnology / Q000639:trends; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D011487:Protein Conformation; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000737:chemistry* / Q000235:genetics
D000970:Antineoplastic Agents; D011994:Recombinant Proteins